FDA Adverse Event Injury Summary report: N

REDO SINGLE LUMEN TPN CATHETER SET

MDR report key: 9612840 · Received January 21, 2020

Report

Report Number
1820334-2020-00182
Event Type
Injury
Date Received
January 21, 2020
Date of Event
November 9, 2019
Report Date
April 9, 2020
Manufacturer
COOK INC
Product Code
FOZ
UDI-DI
00827002079335
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
PL
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 0

BLANK FIELDS ON THIS FORM INDICATE THE INFORMATION IS UNCHANGED, UNKNOWN OR UNAVAILABLE. INVESTIGATION ¿ EVALUATION: IT WAS REPORTED BY (B)(6) MEMORIAL IN POLAND THAT A CATHETER RUPTURE HAD OCCURRED. THE PATIENT WAS 6-YEAR-OLD MALE WEIGHING 18 KILOGRAMS. HE HAD SEVERE SYMPTOMS OF CIRCULATORY FAILURE. THE COMPLAINT DEVICE WAS REPORTED TO BE A REDO SINGLE LUMEN TPN CATHETER SET (RPN: C-TPNS-6.5-90-REDO, LOT NUMBER 9123936). THE DEVICE WAS PLACED ON (B)(6) 2019. IT WAS REPORTED TO HAVE BEEN SUTURED TO THE PATIENT. FIVE DAYS LATER, ON (B)(6) 2019 IT WAS DISCOVERED THAT THE DEVICE HAD RUPTURED. THE NURSE DISCOVERED MASSIVE BLEEDING DURING THE NIGHT WHEN THE PATIENT WAS SLEEPING. THE BLOOD LOSS WAS REPORTED TO BE FROM THE PART OF THE CATHETER THAT WAS OUTSIDE OF THE PATIENT. THE CUSTOMER INDICATED THAT THE PATIENT WAS BEDRIDDEN. AS A RESULT OF THE DEVICE FAILURE, EMERGENT REMOVAL OF THE DEVICE WAS COMPLETED. THE PATIENT EXPERIENCED HEMORRHAGE AND TEMPORARY HEMODYNAMIC DESTABILIZATION DUE TO INTERRUPTED DELIVERY OF INOTROPIC DRUGS. AN EMERGENT INSERTION OF A CENTRAL LINE WAS COMPLETED AFTER THE RUPTURE. A REVIEW OF THE COMPLAINT HISTORY, DEVICE HISTORY RECORD, INSTRUCTIONS FOR USE (IFU) AND QUALITY CONTROL , AS WELL AS A VISUAL INSPECTION OF THE RETURNED DEVICE WERE CONDUCTED DURING THE INVESTIGATION. THE VISUAL INSPECTION OF THE COMPLAINT DEVICE NOTED THE DEVICE WAS RETURNED SEPARATED IN TWO SEGMENTS. THE END OF THE PROXIMAL SEGMENT HAS A STRAIGHT CUT, WHILE THE POINT OF SEPARATION ON THE DISTAL SEGMENT HAD A FLARED APPEARANCE. THIS FLARED SECTION WAS NOTED TO BE THE POINT OF RUPTURE. ADDITIONALLY, IT WAS NOTED THE POINTS OF SEPARATION DO NOT HAVE MATING ENDS, LEADING TO THE PROBABILITY THAT THERE WAS A SEGMENT OF THE DEVICE THAT WAS NOT RETURNED. THE RETURNED DEVICE SHOWS MARKS THAT APPEAR TO BE SUTURE MARKS IN AN AREA THAT DOES NOT HAVE A SUTURE RING. ADDITIONALLY, A DOCUMENT BASED INVESTIGATION EVALUATION WAS PERFORMED. A REVIEW OF THE DEVICE MASTER RECORD FOUND THAT SUFFICIENT INSPECTION ACTIVITIES ARE IN PLACE TO IDENTIFY THIS FAILURE MODE PRIOR TO DISTRIBUTION. A REVIEW OF THE DEVICE HISTORY RECORD FOR THIS DEVICE LOT FOUND NO RELATED NONCONFORMANCES OR ADDITIONAL COMPLAINTS. THERE IS NO EVIDENCE TO SUGGEST THERE IS ANY NONCONFORMING PRODUCT IN HOUSE OR OUT IN THE FIELD. A REVIEW OF THE PRODUCT LABELING FOR THE DEVICE WAS COMPLETED. THE INSTRUCTIONS FOR USE STATE THE FOLLOWING INSTRUCTIONS RELATED TO THE REPORTED FAILURE MODE: EXTREME CAUTION MUST BE USED IN PLACEMENT AND MONITORING. SILICONE CATHETERS ARE NOT DESIGNED FOR POWER INJECTION. CATHETER RUPTURE MAY OCCUR. USE OF A 10 ML SYRINGE OR LARGER WILL REDUCE THE RISK OF CATHETER RUPTURE. BASED ON THE INFORMATION PROVIDED, INSPECTION OF THE RETURNED PRODUCT, AND THE RESULTS OF THE INVESTIGATION, THE CAUSE COULD BE TRACED TO USER ERROR. IT IS POSSIBLE THAT THE SUTURE THAT WAS PLACED ON THE LUMEN OF THE DEVICE WAS PLACED TOO TIGHT AND PLACED CIRCUMFERENTIAL PRESSURE ON THE LUMEN OF THE CATHETER. THIS PRESSURE, IN ADDITION TO ANY TENSION ON THE LINE, COULD HAVE CAUSED THE SEPARATION. THE APPROPRIATE PERSONNEL HAVE BEEN NOTIFIED. PER THE QUALITY ENGINEERING RISK ASSESSMENT, NO FURTHER ACTION IS REQUIRED. COOK WILL CONTINUE TO MONITOR FOR SIMILAR COMPLAINTS. THIS REPORT IS REQUIRED BY THE FDA UNDER 21 CFR PART 803 AND IS BASED ON UNCONFIRMED INFORMATION SUBMITTED BY OTHERS. NEITHER THE SUBMISSION OF THIS REPORT NOR ANY STATEMENT CONTAINED HEREIN IS INTENDED TO BE AN ADMISSION THAT ANY COOK DEVICE IS DEFECTIVE OR MALFUNCTIONED, THAT A DEATH OR SERIOUS INJURY OCCURRED, NOR THAT ANY COOK DEVICE CAUSED, CONTRIBUTED TO, OR IS LIKELY TO CAUSE OR CONTRIBUTE TO A DEATH OR SERIOUS INJURY IF A MALFUNCTION OCCURRED.

Additional Manufacturer Narrative · 0

THIS REPORT INCLUDES INFORMATION KNOWN AT THIS TIME. A FOLLOW-UP REPORT WILL BE SUBMITTED SHOULD ADDITIONAL RELEVANT INFORMATION BECOME AVAILABLE. THIS REPORT IS REQUIRED BY THE FDA UNDER 21 CFR PART 803 AND IS BASED ON UNCONFIRMED INFORMATION SUBMITTED BY OTHERS. NEITHER THE SUBMISSION OF THIS REPORT NOR ANY STATEMENT CONTAINED HEREIN IS INTENDED TO BE AN ADMISSION THAT ANY COOK DEVICE IS DEFECTIVE OR MALFUNCTIONED, THAT A DEATH OR SERIOUS INJURY OCCURRED, NOR THAT ANY COOK DEVICE CAUSED, CONTRIBUTED TO, OR IS LIKELY TO CAUSE OR CONTRIBUTE TO A DEATH OR SERIOUS INJURY IF A MALFUNCTION OCCURRED.

Description of Event or Problem · 0

NO ADDITIONAL PATIENT/EVENT DETAILS HAVE BEEN RECEIVED SINCE THE PREVIOUS MEDWATCH REPORT WAS SENT.

Description of Event or Problem · 0

ADDITIONAL INFORMATION REGARDING THE PATIENT, EVENT, AND DEVICE WAS RECEIVED ON 03FEB2020. IT WAS REPORTED THAT THE CATHETER DISSECTED/DELAMINATED "IN THE MIDDLE OF THE CATHETER PART WHICH IS OUTSIDE THE PATIENT". THE DEVICE DID NOT SEPARATE BUT PERFORATED (DELAMINATED) ALONG THE CATHETER. THE DEVICE FAILURE WAS REPORTED TO HAVE HAPPENED FIVE DAYS AFTER IMPLANTATION AND DURING THE NIGHT AS THE PATIENT WAS SLEEPING WHILE NO TREATMENT OR CATHETER MAINTENANCE WAS BEING PERFORMED. THE PLACEMENT SITE FOR THE DEVICE WAS ON THE "RIGHT". THE DEVICE WAS SUTURED TO THE PATIENT, WHO WAS BEDRIDDEN. THE PATIENT WAS ON INOTROPIC THERAPY. THE NURSE OBSERVED "MASSIVE BLEEDING" FROM THE PATIENT AT NIGHT AND THE CATHETER WAS IMMEDIATELY REMOVED AND REPLACED BY A CVC DEVICE.

Additional Manufacturer Narrative · 1

INITIAL REPORTER: POSTAL CODE: (B)(6). OCCUPATION: SALES REP. PMA/510(K) NUMBER : PRE-AMENDMENT (B)(4). THIS REPORT INCLUDES INFORMATION KNOWN AT THIS TIME. A FOLLOW-UP REPORT WILL BE SUBMITTED SHOULD ADDITIONAL RELEVANT INFORMATION BECOME AVAILABLE.

Description of Event or Problem · 1

IT WAS REPORTED THAT A SINGLE LUMEN TPN CATHETER SET RUPTURED. TEMPORARY HEMODYNAMIC DESTABILIZATION OCCURRED IN THE PATIENT DUE TO THE INTERRUPTED DELIVERY OF INOTROPIC DRUGS. THE CATHETER WAS REMOVED AND A CENTRAL LINE WAS PLACED EMERGENTLY. ADDITIONAL INFORMATION HAS BEEN REQUESTED RELATED TO THE PLACEMENT OF THE DEVICE, EVENT, CATHETER MAINTENANCE, AND ACTIVITY LEVEL OF PATIENT BUT IS NOT AVAILABLE AT THE TIME OF THIS REPORT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
73021 REDO SINGLE LUMEN TPN CATHETER SET FOZ CATHETER, INTRAVASCULAR, THERAPEUTIC, SHORT-TERM LESS THAN 30 DAYS FOZ COOK INC N/A 9123936 00827002079335

Patients

Seq Age Sex Outcome Treatment
1 6 YR Required Intervention